AlzeCure Pharma: Positive FDA feedback regarding ACD440 in orphan disease
13 juni, 08:11
13 juni, 08:11
Redeye comments on yesterday’s news that AlzeCure has received positive feedback from the FDA regarding the clinical path for ACD440 in the rare pain disorder erythromelalgia.
13 juni, 08:11
Redeye comments on yesterday’s news that AlzeCure has received positive feedback from the FDA regarding the clinical path for ACD440 in the rare pain disorder erythromelalgia.
Veckans analyser
Fortnox-budet
Veckans analyser
Fortnox-budet
1 DAG %
Senast
Creades
13 juni, 18:51
Creades och Bure gör stor halvledarinvestering
OMX Stockholm 30
1 DAG %
Senast
2 459,61